<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Palliat Med</journal-id><journal-id journal-id-type="iso-abbrev">Palliat Med</journal-id><journal-id journal-id-type="publisher-id">PMJ</journal-id><journal-id journal-id-type="hwp">sppmj</journal-id><journal-title-group><journal-title>Palliative Medicine</journal-title></journal-title-group><issn pub-type="ppub">0269-2163</issn><issn pub-type="epub">1477-030X</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage UK: London, England</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29299957</article-id><article-id pub-id-type="pmc">5881790</article-id><article-id pub-id-type="doi">10.1177/0269216317747199</article-id><article-id pub-id-type="publisher-id">10.1177_0269216317747199</article-id><article-categories><subj-group subj-group-type="heading"><subject>Palliative Care Interventions</subject><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></subj-group></article-categories><title-group><article-title>The &#x02018;Cancer Home-Life Intervention&#x02019;: A randomised controlled trial evaluating the efficacy of an occupational therapy&#x02013;based intervention in people with advanced cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6362-410X</contrib-id><name><surname>Pilegaard</surname><given-names>Marc Sampedro</given-names></name><xref ref-type="aff" rid="aff1-0269216317747199">1</xref><xref ref-type="aff" rid="aff2-0269216317747199">2</xref><xref ref-type="corresp" rid="corresp1-0269216317747199"/></contrib><contrib contrib-type="author"><name><surname>la Cour</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="aff1-0269216317747199">1</xref><xref ref-type="aff" rid="aff2-0269216317747199">2</xref></contrib><contrib contrib-type="author"><name><surname>Gregersen Oestergaard</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="aff3-0269216317747199">3</xref><xref ref-type="aff" rid="aff4-0269216317747199">4</xref></contrib><contrib contrib-type="author"><name><surname>Johnsen</surname><given-names>Anna Thit</given-names></name><xref ref-type="aff" rid="aff5-0269216317747199">5</xref><xref ref-type="aff" rid="aff6-0269216317747199">6</xref></contrib><contrib contrib-type="author"><name><surname>Lindahl-Jacobsen</surname><given-names>Line</given-names></name><xref ref-type="aff" rid="aff7-0269216317747199">7</xref></contrib><contrib contrib-type="author"><name><surname>H&#x000f8;jris</surname><given-names>Inger</given-names></name><xref ref-type="aff" rid="aff8-0269216317747199">8</xref></contrib><contrib contrib-type="author"><name><surname>Brandt</surname><given-names>&#x000c5;se</given-names></name><xref ref-type="aff" rid="aff1-0269216317747199">1</xref><xref ref-type="aff" rid="aff2-0269216317747199">2</xref><xref ref-type="aff" rid="aff9-0269216317747199">9</xref></contrib></contrib-group><aff id="aff1-0269216317747199"><label>1</label>The Research Initiative of Activity Studies and Occupational Therapy, Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark</aff><aff id="aff2-0269216317747199"><label>2</label>OPEN &#x02013; Odense Patient Data Explorative Network, Odense University Hospital, University of Southern Denmark, Odense, Denmark</aff><aff id="aff3-0269216317747199"><label>3</label>Department of Physiotherapy and Occupational Therapy, Aarhus University Hospital, Aarhus, Denmark</aff><aff id="aff4-0269216317747199"><label>4</label>Department of Public Health, Aarhus University, Aarhus, Denmark</aff><aff id="aff5-0269216317747199"><label>5</label>Department of Psychology, University of Southern Denmark, Odense, Denmark</aff><aff id="aff6-0269216317747199"><label>6</label>Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark</aff><aff id="aff7-0269216317747199"><label>7</label>University College Zealand, Sor&#x000f8;, Denmark</aff><aff id="aff8-0269216317747199"><label>8</label>Department of Oncology, Aarhus University Hospital, Aarhus, Denmark</aff><aff id="aff9-0269216317747199"><label>9</label>Centre for Disability and Mental Vulnerability, The National Board of Social Services, Odense, Denmark</aff><author-notes><corresp id="corresp1-0269216317747199">Marc Sampedro Pilegaard, The Research Initiative of Activity Studies and Occupational Therapy, Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense C, Denmark. Email: <email>mpilegaard@health.sdu.dk</email></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2018</year></pub-date><volume>32</volume><issue>4</issue><fpage>744</fpage><lpage>756</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="open-access" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><sec id="section1-0269216317747199"><title>Background:</title><p>People with advanced cancer face difficulties with their everyday activities at home that may reduce their health-related quality of life. To address these difficulties, we developed the &#x02018;Cancer Home-Life Intervention&#x02019;.</p></sec><sec id="section2-0269216317747199"><title>Aim:</title><p>To evaluate the efficacy of the &#x02018;Cancer Home Life-Intervention&#x02019; compared with usual care with regard to patients&#x02019; performance of, and participation in, everyday activities, and their health-related quality of life.</p></sec><sec id="section3-0269216317747199"><title>Design and intervention:</title><p>A randomised controlled trial (<ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> NCT02356627). The &#x02018;Cancer Home-Life Intervention&#x02019; is a brief, tailored, occupational therapy&#x02013;based and adaptive programme for people with advanced cancer targeting the performance of their prioritised everyday activities.</p></sec><sec id="section4-0269216317747199"><title>Setting/participants:</title><p>Home-living adults diagnosed with advanced cancer experiencing functional limitations were recruited from two Danish hospitals. They were assessed at baseline, and at 6 and 12&#x02009;weeks of follow-up. The primary outcome was activities of daily living motor ability. Secondary outcomes were activities of daily living process ability, difficulty performing prioritised everyday activities, participation restrictions and health-related quality of life.</p></sec><sec id="section5-0269216317747199"><title>Results:</title><p>A total of 242 participants were randomised either to the intervention group (<italic>n</italic>&#x02009;=&#x02009;121) or the control group (<italic>n</italic>&#x02009;=&#x02009;121). No effect was found on the primary outcome (between-group mean change: &#x02212;0.04 logits (95% confidence interval: &#x02212;0.23 to 0.15); <italic>p&#x02009;=</italic>&#x02009;0.69). Nor was any effect on the secondary outcomes observed.</p></sec><sec id="section6-0269216317747199"><title>Conclusion:</title><p>In most cases, the &#x02018;Cancer Home-Life Intervention&#x02019; was delivered through only one home visit and one follow-up telephone contact, which not was effective in maintaining or improving participants&#x02019; everyday activities and health-related quality of life. Future research should pay even more attention to intervention development and feasibility testing.</p></sec></abstract><kwd-group><kwd>Activities of daily living</kwd><kwd>independent living</kwd><kwd>neoplasms</kwd><kwd>occupational therapy</kwd><kwd>quality of life</kwd><kwd>palliative care</kwd><kwd>controlled clinical trial</kwd></kwd-group><funding-group><award-group id="award1-0269216317747199"><funding-source id="funding1-0269216317747199"><institution-wrap><institution>Kr&#x000e6;ftens Bek&#x000e6;mpelse</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100008363</institution-id></institution-wrap></funding-source><award-id rid="funding1-0269216317747199">R53-A2783</award-id></award-group><award-group id="award2-0269216317747199"><funding-source id="funding2-0269216317747199"><institution-wrap><institution>TrygFonden</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100007437</institution-id></institution-wrap></funding-source><award-id rid="funding2-0269216317747199">R53-A2783</award-id></award-group></funding-group></article-meta></front><body><boxed-text id="boxed-text1-0269216317747199" orientation="portrait" position="float"><p>
<bold>What is already known about the topic?</bold>
</p><list list-type="bullet" id="list1-0269216317747199"><list-item><p>Many people with advanced cancer want to stay at home for as long as possible.</p></list-item><list-item><p>Research shows that people with advanced cancer have difficulties performing and participating in everyday activities at home, and this may reduce their health-related quality of life (HRQoL).</p></list-item><list-item><p>Only two pilot studies and an underpowered randomised controlled trial (RCT) have so far investigated the efficacy of occupational therapy&#x02013;based (OT-based) interventions that support people with advanced cancer in performing and participating in everyday activities.</p></list-item></list><p>
<bold>What this paper adds?</bold>
</p><list list-type="bullet" id="list2-0269216317747199"><list-item><p>It was feasible to conduct a full-scale RCT for people with advanced cancer.</p></list-item><list-item><p>The majority of the participants wanted and needed OT-based interventions that supported their everyday activities at home.</p></list-item><list-item><p>We found no effect of the &#x02018;Cancer Home-Life Intervention&#x02019; on activities of daily living (ADL) performance, difficulty performing prioritised everyday activities, autonomy and participation, or HRQoL.</p></list-item></list><p>
<bold>Implications for practice, theory or policy</bold>
</p><list list-type="bullet" id="list3-0269216317747199"><list-item><p>This is the first full-scale, sufficiently powered RCT to investigate the efficacy of an OT-based intervention in people with advanced cancer.</p></list-item><list-item><p>Future RCTs evaluating efficacy of OT-based interventions in this population require even more attention to intervention development and feasibility testing.</p></list-item><list-item><p>Future studies need to consider if patients selected for their studies should have more severe functional limitations than was the case in our study and if the intervention is relevant to patients.</p></list-item></list></boxed-text><sec sec-type="intro" id="section7-0269216317747199"><title>Introduction</title><p>More people live longer with advanced cancer,<sup><xref rid="bibr1-0269216317747199" ref-type="bibr">1</xref>,<xref rid="bibr2-0269216317747199" ref-type="bibr">2</xref></sup> and many of them want to stay at home for as long as possible.<sup><xref rid="bibr3-0269216317747199" ref-type="bibr">3</xref>,<xref rid="bibr4-0269216317747199" ref-type="bibr">4</xref></sup> Research shows that most people with advanced cancer have difficulties performing and participating in everyday activities,<sup><xref rid="bibr5-0269216317747199" ref-type="bibr">5</xref><xref rid="bibr6-0269216317747199" ref-type="bibr"/><xref rid="bibr7-0269216317747199" ref-type="bibr"/><xref rid="bibr8-0269216317747199" ref-type="bibr"/><xref rid="bibr9-0269216317747199" ref-type="bibr"/>&#x02013;<xref rid="bibr10-0269216317747199" ref-type="bibr">10</xref></sup> which can affect their ability to stay at home and in turn reduce their health-related quality of life (HRQoL).<sup><xref rid="bibr11-0269216317747199" ref-type="bibr">11</xref></sup> Everyday activities refer to everything people do in daily life, like self-care and housework (activities of daily living (ADL)), work and leisure,<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup> with ADL being essential for maintaining independent living.<sup><xref rid="bibr13-0269216317747199" ref-type="bibr">13</xref></sup></p><p>Several qualitative studies emphasise that maintaining everyday activities and independence is an important priority for people with advanced cancer.<sup><xref rid="bibr14-0269216317747199" ref-type="bibr">14</xref><xref rid="bibr15-0269216317747199" ref-type="bibr"/><xref rid="bibr16-0269216317747199" ref-type="bibr"/><xref rid="bibr17-0269216317747199" ref-type="bibr"/>&#x02013;<xref rid="bibr18-0269216317747199" ref-type="bibr">18</xref></sup> However, Cheville et al.<sup><xref rid="bibr5-0269216317747199" ref-type="bibr">5</xref></sup> showed that more than 43% of women with metastatic breast cancer (<italic>N</italic>&#x02009;=&#x02009;163) had difficulties performing ADL. Rainbird et al.<sup><xref rid="bibr10-0269216317747199" ref-type="bibr">10</xref></sup> revealed that 10%&#x02013;30% of people with advanced cancer (<italic>N</italic>&#x02009;=&#x02009;246) needed help with housework and preparing meals, 31% feared losing their independence and 40% were frustrated by being unable to participate in the activities they used to do previously. This resonates with a study by Johnsen et al.<sup><xref rid="bibr6-0269216317747199" ref-type="bibr">6</xref></sup> where 29% (<italic>N</italic>&#x02009;=&#x02009;901) of people with advanced cancer did not receive the help they need concerning ADL. Similarly, W&#x000e6;hrens et al.<sup><xref rid="bibr8-0269216317747199" ref-type="bibr">8</xref></sup> found that among people with advanced cancer, 53% (<italic>N</italic>&#x02009;=&#x02009;136) had an observed ADL performance level requiring assistance to perform ADL and prioritised everyday activity problems mainly within mobility and domestic life.<sup><xref rid="bibr9-0269216317747199" ref-type="bibr">9</xref></sup> Thus, to support people with advanced cancer in living their lives as fully as possible, palliative care must also focus on enabling the patients&#x02019; everyday activities.</p><p>A growing body of rehabilitation research on people with advanced cancer demonstrates effects on function and independence.<sup><xref rid="bibr19-0269216317747199" ref-type="bibr">19</xref><xref rid="bibr20-0269216317747199" ref-type="bibr"/><xref rid="bibr21-0269216317747199" ref-type="bibr"/><xref rid="bibr22-0269216317747199" ref-type="bibr"/><xref rid="bibr23-0269216317747199" ref-type="bibr"/><xref rid="bibr24-0269216317747199" ref-type="bibr"/><xref rid="bibr25-0269216317747199" ref-type="bibr"/>&#x02013;<xref rid="bibr26-0269216317747199" ref-type="bibr">26</xref></sup> These studies are largely exercise-based interventions.<sup><xref rid="bibr22-0269216317747199" ref-type="bibr">22</xref><xref rid="bibr23-0269216317747199" ref-type="bibr"/><xref rid="bibr24-0269216317747199" ref-type="bibr"/><xref rid="bibr25-0269216317747199" ref-type="bibr"/>&#x02013;<xref rid="bibr26-0269216317747199" ref-type="bibr">26</xref></sup> Occupational therapy&#x02013;based (OT-based) interventions bring a different approach to existing palliative care interventions by intervening more directly on the target population&#x02019;s everyday activity problems.<sup><xref rid="bibr27-0269216317747199" ref-type="bibr">27</xref></sup> A key principle underpinning most OT-based interventions is a person-centred approach where the interventions are tailored to patient&#x02019;s priorities,<sup><xref rid="bibr27-0269216317747199" ref-type="bibr">27</xref></sup> which is in accordance with palliative care principles.<sup><xref rid="bibr28-0269216317747199" ref-type="bibr">28</xref></sup> To our knowledge, only two pilot randomised controlled trials (RCT)<sup><xref rid="bibr29-0269216317747199" ref-type="bibr">29</xref>,<xref rid="bibr30-0269216317747199" ref-type="bibr">30</xref></sup> and one underpowered full-scale RCT<sup><xref rid="bibr31-0269216317747199" ref-type="bibr">31</xref></sup> have investigated OT-based interventions in people with advanced cancer. All three studies<sup><xref rid="bibr29-0269216317747199" ref-type="bibr">29</xref><xref rid="bibr30-0269216317747199" ref-type="bibr"/>&#x02013;<xref rid="bibr31-0269216317747199" ref-type="bibr">31</xref></sup> included adaptive interventions delivered by OTs, that is, interventions that include intrinsic changes, like change of habits and behaviour, and/or extrinsic changes, for example, provision of assistive technology and home modification.<sup><xref rid="bibr32-0269216317747199" ref-type="bibr">32</xref></sup> Overall, the studies<sup><xref rid="bibr29-0269216317747199" ref-type="bibr">29</xref><xref rid="bibr30-0269216317747199" ref-type="bibr"/>&#x02013;<xref rid="bibr31-0269216317747199" ref-type="bibr">31</xref></sup> showed that delivering an adaptive intervention focused on everyday activities for people with advanced cancer was feasible, although two of the studies had significant problems with recruitment and attrition.<sup><xref rid="bibr30-0269216317747199" ref-type="bibr">30</xref>,<xref rid="bibr31-0269216317747199" ref-type="bibr">31</xref></sup> Due to the limited evidence of OT-based interventions in people with advanced cancer, we developed the &#x02018;Cancer Home-Life Intervention&#x02019;.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup></p><p>This study evaluates the efficacy of the &#x02018;Cancer Home-Life Intervention&#x02019; and usual care compared with usual care alone in people with advanced cancer living at home in relation to ADL performance, difficulty performing prioritised everyday activities, autonomy and participation, and HRQoL.</p></sec><sec sec-type="methods" id="section8-0269216317747199"><title>Methods</title><sec id="section9-0269216317747199"><title>Trial design</title><p>This parallel group, superiority RCT with balanced randomisation (1:1) consecutively recruited participants from oncology units at Aarhus University Hospital (AUH), Denmark, and Odense University Hospital (OUH), Denmark, from February 2015 to October 2016. The Ethics Committee decided that no approval was required for this study (S-20122000-96). The study was approved by the Danish Data Protection Agency (FN 215-57-0008) and registered at <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> (NCT02356627). A previous article describes the details of the protocol.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup></p></sec><sec id="section10-0269216317747199"><title>Participants</title><p>Eligible participants were home-living adults (&#x02a7e;18&#x02009;years) diagnosed with advanced cancer by their responsible oncologist, had a World Health Organization (WHO) Performance Status (PS) 1&#x02013;2 (see <xref ref-type="table" rid="table5-0269216317747199">Appendix 1</xref>)<sup><xref rid="bibr33-0269216317747199" ref-type="bibr">33</xref></sup> and lived at home or in sheltered living within a maximum radius of 60&#x02009;km from AUH or on the island of Funen. Ineligible participants were living in a nursing home or hospice, were cognitively impaired or had insufficient Danish language skills. The enrolled participants provided written informed consent.</p></sec><sec id="section11-0269216317747199"><title>Intervention and control</title><p>The &#x02018;Cancer Home-Life Intervention&#x02019; is a tailored, OT-based, adaptive programme for people with advanced cancer delivered by OTs. It aims to enable people to perform and participate in the everyday activities at home that they prioritise but have difficulties performing (e.g. ADL, leisure, social activities) through application of one or more of the six components (<xref ref-type="table" rid="table1-0269216317747199">Table 1</xref>), with component 1 being mandatory. The rationale of the intervention is to compensate for their functional limitations by providing the participant with adaptive strategies that have the potential to give people more energy to perform and participate in the everyday activities they prioritise. The adaptive components include intrinsic and extrinsic changes, like supporting them to prioritise time and to divide activities into smaller parts, teaching them strategies to use their body in a more efficient and safe manner, and providing assistive technology and home modifications. All components are delivered through instruction in and practice of the selected strategies. Each participant is offered 1&#x02013;3 face-to-face home visits lasting max 120&#x02009;min and 1&#x02013;3 telephone contacts after the first intervention visit to reinforce intervention strategy use and resolve any emerging problems. The tailoring (which components and the number of components and home visits) is based on the participant&#x02019;s type of activity problems. For details, see the protocol and <xref ref-type="table" rid="table1-0269216317747199">Table 1</xref>.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup></p><table-wrap id="table1-0269216317747199" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Description of the &#x02018;Cancer Home-Life Intervention&#x02019;.</p></caption><alternatives><graphic xlink:href="10.1177_0269216317747199-table1"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Intervention features</th><th align="left" colspan="1" rowspan="1">Intensity and content</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Setting</td><td colspan="1" rowspan="1">Participant&#x02019;s home</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Individual</td></tr><tr><td colspan="1" rowspan="1">Intervention provider</td><td colspan="1" rowspan="1">Occupational therapist</td></tr><tr><td colspan="1" rowspan="1">Number of home visits</td><td colspan="1" rowspan="1">1&#x02013;3</td></tr><tr><td colspan="1" rowspan="1">Intervention period</td><td colspan="1" rowspan="1">&#x02a7d;3&#x02009;weeks</td></tr><tr><td colspan="1" rowspan="1">Time per visit</td><td colspan="1" rowspan="1">60&#x02013;120&#x02009;min</td></tr><tr><td colspan="1" rowspan="1">Telephone follow-up</td><td colspan="1" rowspan="1">1&#x02013;3</td></tr><tr><td colspan="2" rowspan="1">
<italic>Mandatory component</italic>
</td></tr><tr><td colspan="1" rowspan="1">Component 1</td><td colspan="1" rowspan="1"><italic>Initial interview</italic>
<break/>Identify prioritised everyday activity problems in the home environment. The I-OT and the participant schedule an intervention plan together.They select which of the five optional components that should be included, tailoring the intervention to the participant&#x02019;s needs with their prioritised everyday activities.</td></tr><tr><td colspan="2" rowspan="1">
<italic>Optional components</italic>
</td></tr><tr><td colspan="1" rowspan="1">Component 2</td><td colspan="1" rowspan="1"><italic>Prioritisation of resources, energy and activities</italic>
<break/>Instructing participant in energy conservation techniques, talking about time to rest during the day and delegating activities to family members or other people, for instance, so that participants can perform and participate in their prioritised everyday activities.</td></tr><tr><td colspan="1" rowspan="1">Component 3</td><td colspan="1" rowspan="1"><italic>Adaptation of activities</italic>
<break/>Instructing participant in how to perform prioritised everyday activities in alternative ways according to symptom management, for example, by working in a seated position instead of standing, splitting tasks into actions, reordering actions and asking for assistance.</td></tr><tr><td colspan="1" rowspan="1">Component 4</td><td colspan="1" rowspan="1"><italic>Adaptation of posture and seating positioning</italic>
<break/>Instructing participants and practising seated positioning and ergonomics when performing their prioritised everyday activities, for example, lifting techniques, how to obtain a good seating/standing position during activity and how to obtain a good resting position in bed or other places.</td></tr><tr><td colspan="1" rowspan="1">Component 5</td><td colspan="1" rowspan="1"><italic>Provision of assistive technology</italic>
<break/>Selecting assistive devices for participants and instructing and practicing in using them when performing prioritised everyday activities, for example, mobility devices, devices for gardening, devices for handling cold objects.</td></tr><tr><td colspan="1" rowspan="1">Component 6</td><td colspan="1" rowspan="1"><italic>Modification of the physical home environment</italic>
<break/>Providing home safety and home modification, for example, rearranging furniture or setting up handrails, and ensuring home safety.</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-0269216317747199"><p>I-OT: intervention occupational therapist.</p></fn></table-wrap-foot></table-wrap><p>Usual care comprised home-care, palliative care and/or rehabilitation that sometimes also involved OT as provided by the participants&#x02019; home municipality.</p></sec><sec id="section12-0269216317747199"><title>Procedures</title><p>Six intervention occupational therapists (I-OTs) performed the intervention. The I-OTs participated in a one-day workshop where they trained in performing the intervention with time to discuss the different parts of the intervention with the developers in order to standardise the delivery of the intervention. The I-OTs participated in three meetings during the study period to enhance the fidelity of the intervention. During delivery, the I-OTs monitored their fidelity to the intervention manual by reporting which components they provided to each participant.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup> Eight trained data-collection occupational therapists (D-OTs) collected the data from February 2015 to December 2016. They collected baseline (T1) and 12-week (T3) data in the participants&#x02019; homes. Six-week (T2) data were collected using a postal questionnaire and telephone interview.</p></sec><sec id="section13-0269216317747199"><title>Outcome measures</title><sec id="section14-0269216317747199"><title>ADL performance</title><p>The Assessment of Motor and Process Skills (AMPS) is an observation-based instrument measuring the observed quality of ADL task performance. It has two domains: ADL motor ability and ADL process ability. Higher positive measures represent better ADL performance. Measures of &#x02a7e;0.3 logits on both indicate a clinically relevant change. ADL motor ability measures above 2.0 logits and ADL process ability measures above 1.0 logits represent competent ADL performance (no physical effort, efficient, safe and independent). The AMPS has demonstrated sound psychometric properties in terms of validity and reliability among people with cancer<sup><xref rid="bibr34-0269216317747199" ref-type="bibr">34</xref>,<xref rid="bibr35-0269216317747199" ref-type="bibr">35</xref></sup> and sensitivity to change in other diagnostic groups.<sup><xref rid="bibr13-0269216317747199" ref-type="bibr">13</xref></sup></p></sec><sec id="section15-0269216317747199"><title>Difficulties performing the participants&#x02019; prioritised everyday activities</title><p>The Individually Prioritised Problem Assessment (IPPA) is a generic, structured interview&#x02013;based instrument that is used to identify participants&#x02019; prioritised everyday activities and the ease/difficulty participants encounter when performing them.<sup><xref rid="bibr36-0269216317747199" ref-type="bibr">36</xref></sup> The participants prioritise up to seven activity problems and rate the importance and difficulty of these problems. In this study, prioritised activity problems were limited to those in the home environment. IPPA scores range from 1 to 25, with a higher score indicating a greater degree of difficulty performing prioritised everyday activities. The IPPA has been found to be a responsive and valid instrument in elderly people.<sup><xref rid="bibr37-0269216317747199" ref-type="bibr">37</xref>,<xref rid="bibr38-0269216317747199" ref-type="bibr">38</xref></sup></p></sec><sec id="section16-0269216317747199"><title>Autonomy and participation</title><p>The Danish version (IPA-DK) of the Impact on Participation and Autonomy Questionnaire (IPAQ) is a generic questionnaire used to identify person-perceived participation restrictions. It has five domains.<sup><xref rid="bibr39-0269216317747199" ref-type="bibr">39</xref></sup> We used autonomy indoors, family roles and social relations subscales with scores ranging from 0&#x02013;4, with 0 being no participation restrictions and 4 being perceived severe participation restrictions. The scores were dichotomised into no perceived restrictions (score 0 and 1) and perceived restrictions (scores 2, 3 and 4). The IPA-DK and IPAQ have demonstrated acceptable psychometric properties regarding validity, reliability and sensitivity.<sup><xref rid="bibr40-0269216317747199" ref-type="bibr">40</xref><xref rid="bibr41-0269216317747199" ref-type="bibr"/><xref rid="bibr42-0269216317747199" ref-type="bibr"/>&#x02013;<xref rid="bibr43-0269216317747199" ref-type="bibr">43</xref></sup></p></sec><sec id="section17-0269216317747199"><title>HRQoL</title><p>The European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30 (EORTC QLQ C-30) is a cancer-specific questionnaire assessing HRQoL and consists of 15 scales.<sup><xref rid="bibr44-0269216317747199" ref-type="bibr">44</xref></sup> We used the global health status/Quality of Life scale as an overall measure of HRQoL, with scores ranging from 0 to 100, where higher scores indicate better HRQoL.<sup><xref rid="bibr44-0269216317747199" ref-type="bibr">44</xref></sup> The EORTC QLQ C-30 has been found to be a responsive, valid and reliable instrument among people with advanced cancer.<sup><xref rid="bibr45-0269216317747199" ref-type="bibr">45</xref>,<xref rid="bibr46-0269216317747199" ref-type="bibr">46</xref></sup></p></sec></sec><sec id="section18-0269216317747199"><title>Primary outcome</title><list list-type="bullet" id="list4-0269216317747199"><list-item><p>Change in ADL motor ability from T1&#x02013;T3 measured with the AMPS.<sup><xref rid="bibr13-0269216317747199" ref-type="bibr">13</xref></sup></p></list-item></list></sec><sec id="section19-0269216317747199"><title>Secondary outcomes</title><list list-type="bullet" id="list5-0269216317747199"><list-item><p>Change in ADL process ability from T1&#x02013;T3 measured with the AMPS;<sup><xref rid="bibr13-0269216317747199" ref-type="bibr">13</xref></sup></p></list-item><list-item><p>Change in difficulties performing prioritised everyday activities from T1&#x02013;T2 and from T1&#x02013;T3 assessed with the IPPA;<sup><xref rid="bibr36-0269216317747199" ref-type="bibr">36</xref></sup></p></list-item><list-item><p>Probability of no perceived participation restrictions within the domains autonomy indoors, family role and social relations at T2 and T3 assessed by the IPA-DK;<sup><xref rid="bibr39-0269216317747199" ref-type="bibr">39</xref></sup></p></list-item><list-item><p>Change in HRQoL from T1&#x02013;T2 and from T1&#x02013;T3 assessed by the EORTC QLQ C-30.<sup><xref rid="bibr44-0269216317747199" ref-type="bibr">44</xref></sup></p></list-item></list></sec><sec id="section20-0269216317747199"><title>Sample size</title><p>To identify a clinically relevant between-group change of 0.3 logits on the ADL motor ability, we needed to recruit 272 participants with an expected attrition of 32% (<italic>N</italic>&#x02009;=&#x02009;184 would provide 80% power). Alpha was 5% and the standard deviation (SD) 0.727.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup></p></sec><sec id="section21-0269216317747199"><title>Randomisation and masking</title><p>After T1, the D-OTs randomised the participants to one of the two groups using online computer-generated randomisation with a fixed block size prepared by the Odense Patient Data Explorative Network that had no other study involvement.</p><p>Analyses were performed masked for the group allocation. The D-OTs were masked when collecting the outcome measures.</p></sec><sec id="section22-0269216317747199"><title>Analyses</title><p>Descriptive data are presented with mean values and SD, median and interquartile range (IQR), or number and percent. For quantitative outcomes (AMPS, IPPA and EORTC QLQ C-30), change in the intervention group was compared with change in the control group<sup><xref rid="bibr47-0269216317747199" ref-type="bibr">47</xref></sup> using multiple linear regression analyses. Analyses were adjusted for hospital.</p><p>Logistic regression analysis was performed comparing the odds ratio (OR) of not having perceived participation restrictions within the three IPA-DK domains. Between-group change and the OR were presented with 95% confidence intervals (CI).</p><p>Primary analyses were performed as complete case analysis, excluding participants with missing outcome measure values and with invalid AMPS data. Data were analysed according to original group allocation; and two sensitivity analyses were conducted to examine the robustness of the primary analyses:</p><list list-type="order" id="list6-0269216317747199"><list-item><p>Linear regression analysis adjusted for unbalanced variables at T1 between the groups.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup></p></list-item><list-item><p>Mixed linear models to investigate change over time and between-group differences for quantitative outcomes.</p></list-item></list><p><italic>p</italic> values &#x02a7d;0.05 were considered statistically significant. Analyses were performed using STATA 14.</p></sec></sec><sec sec-type="results" id="section23-0269216317747199"><title>Results</title><sec id="section24-0269216317747199"><title>Participants</title><p>Between 16 January 2015 and 28 September 2016, 522 people were invited to participate (<xref ref-type="fig" rid="fig1-0269216317747199">Figure 1</xref>). Measures were completed at T1 by 242 participants who were randomised to intervention (<italic>n</italic>&#x02009;=&#x02009;121) or control (<italic>n</italic>&#x02009;=&#x02009;121). No significant differences for age (<italic>p&#x02009;=&#x02009;</italic>0.29), gender (<italic>p&#x02009;=&#x02009;</italic>0.55), WHO PS (<italic>p&#x02009;=&#x02009;</italic>0.65) and primary cancer type (<italic>p&#x02009;=&#x02009;</italic>0.24) were found between participants and those who declined participation.</p><fig id="fig1-0269216317747199" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Flow chart</p></caption><graphic xlink:href="10.1177_0269216317747199-fig1"/></fig><p>Attrition was almost similar (intervention: 8.3% (T2) and 9.9% (T3)) versus control: 7.4% (T2) and 12.4% (T3)) with death and illness being the main causes. T3 (AMPS: <italic>n</italic>&#x02009;=&#x02009;1 invalid) was completed by 191 participants (<xref ref-type="fig" rid="fig1-0269216317747199">Figure 1</xref>). The number of people included was sufficient to reach the calculated sample size (<italic>N</italic>&#x02009;=&#x02009;184).</p><p>The mean age for the study population was 67.91, slightly more women than men participated (124 (51.2%)), and the majority of the participants were living with a partner (167 (68.9%)). The most common primary cancer types were gastrointestinal (74 (30.6%)), lung (48 (19.8%)) and breast (37 (15.3%)). The mean ADL motor ability was 1.13 logits, namely, far below the competence cut-off (&#x0003c;2.0 logits), indicating safety risk and/or need for assistance during ADL performance. The mean ADL process ability was 0.84 logits, which is just below the competence cut-off (&#x0003c;1.0 logits). Participants encountered difficulties performing their prioritised everyday activities (mean score 14.26 on 1&#x02013;25 scale) and had reduced HRQoL (mean score 58.51 on 0&#x02013;100 scale). They reported almost no perceived participation restrictions within the three subdomains of the IPA-DK (<xref ref-type="table" rid="table2-0269216317747199">Table 2</xref>).</p><table-wrap id="table2-0269216317747199" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Participants&#x02019; baseline characteristics (<italic>N</italic>&#x02009;=&#x02009;242).</p></caption><alternatives><graphic xlink:href="10.1177_0269216317747199-table2"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Study population (<italic>N</italic>&#x02009;=&#x02009;242)</th><th align="left" colspan="1" rowspan="1">Intervention group (<italic>n</italic>&#x02009;=&#x02009;121)</th><th align="left" colspan="1" rowspan="1">Control group (<italic>n</italic>&#x02009;=&#x02009;121)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age (years), mean (SD)</td><td colspan="1" rowspan="1">67.91 (9.00)</td><td colspan="1" rowspan="1">68.67 (8.64)</td><td colspan="1" rowspan="1">67.16 (9.32)</td></tr><tr><td colspan="1" rowspan="1">Women, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">124 (51.2)</td><td colspan="1" rowspan="1">54 (44.6)</td><td colspan="1" rowspan="1">70 (57.9)</td></tr><tr><td colspan="4" rowspan="1">Hospital, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;AUH</td><td colspan="1" rowspan="1">222 (91.7)</td><td colspan="1" rowspan="1">111 (91.7)</td><td colspan="1" rowspan="1">111 (91.7)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;OUH</td><td colspan="1" rowspan="1">20 (8.3)</td><td colspan="1" rowspan="1">10 (8.3)</td><td colspan="1" rowspan="1">10 (8.3)</td></tr><tr><td colspan="1" rowspan="1">Living alone, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">74 (30.7)</td><td colspan="1" rowspan="1">33 (27.5)</td><td colspan="1" rowspan="1">41 (33.9)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">1 (0.4)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">0 (0.00)</td></tr><tr><td colspan="4" rowspan="1">Type of residence, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;House</td><td colspan="1" rowspan="1">168 (69.7)</td><td colspan="1" rowspan="1">85 (70.8)</td><td colspan="1" rowspan="1">83 (68.6)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Apartment</td><td colspan="1" rowspan="1">57 (23.7)</td><td colspan="1" rowspan="1">25 (20.8)</td><td colspan="1" rowspan="1">32 (26.5)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Other</td><td colspan="1" rowspan="1">16 (6.6)</td><td colspan="1" rowspan="1">10 (8.3)</td><td colspan="1" rowspan="1">6 (5.0)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">1 (0.4)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">0 (0.00)</td></tr><tr><td colspan="4" rowspan="1">Education, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;&#x02a7d;10&#x02009;years</td><td colspan="1" rowspan="1">64 (26.7)</td><td colspan="1" rowspan="1">31 (25.8)</td><td colspan="1" rowspan="1">33 (27.5)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;11&#x02013;12&#x02009;years</td><td colspan="1" rowspan="1">63 (26.3)</td><td colspan="1" rowspan="1">37 (30.8)</td><td colspan="1" rowspan="1">26 (21.7)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;&#x0003e;13&#x02009;years</td><td colspan="1" rowspan="1">113 (47.1)</td><td colspan="1" rowspan="1">52 (43.3)</td><td colspan="1" rowspan="1">61 (50.8)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">2 (0.8)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">1 (0.8)</td></tr><tr><td colspan="4" rowspan="1">Comorbidities, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;0</td><td colspan="1" rowspan="1">52 (21.5)</td><td colspan="1" rowspan="1">25 (21.6)</td><td colspan="1" rowspan="1">27 (22.5)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;1&#x02013;3</td><td colspan="1" rowspan="1">161 (66.5)</td><td colspan="1" rowspan="1">79 (68.1)</td><td colspan="1" rowspan="1">82 (68.3)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;&#x0003e;3</td><td colspan="1" rowspan="1">23 (9.5)</td><td colspan="1" rowspan="1">12 (10.3)</td><td colspan="1" rowspan="1">11 (9.2)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">6 (2.5)</td><td colspan="1" rowspan="1">5 (4.1)</td><td colspan="1" rowspan="1">1 (0.8)</td></tr><tr><td colspan="4" rowspan="1">Primary tumour site, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Gastrointestinal</td><td colspan="1" rowspan="1">74 (30.6)</td><td colspan="1" rowspan="1">44 (36.4)</td><td colspan="1" rowspan="1">30 (24.8)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Lung</td><td colspan="1" rowspan="1">48 (19.8)</td><td colspan="1" rowspan="1">22 (18.2)</td><td colspan="1" rowspan="1">26 (21.5)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Breast</td><td colspan="1" rowspan="1">37 (15.3)</td><td colspan="1" rowspan="1">16 (13.2)</td><td colspan="1" rowspan="1">21 (17.4)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Prostate</td><td colspan="1" rowspan="1">30 (12.4)</td><td colspan="1" rowspan="1">16 (13.2)</td><td colspan="1" rowspan="1">14 (11.6)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Head and neck</td><td colspan="1" rowspan="1">17 (7.0)</td><td colspan="1" rowspan="1">10 (8.3)</td><td colspan="1" rowspan="1">7 (5.8)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Bladder</td><td colspan="1" rowspan="1">15 (6.2)</td><td colspan="1" rowspan="1">6 (5.0)</td><td colspan="1" rowspan="1">9 (7.4)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Gynaecological</td><td colspan="1" rowspan="1">14 (5.8)</td><td colspan="1" rowspan="1">2 (1.2)</td><td colspan="1" rowspan="1">12 (9.9)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Other</td><td colspan="1" rowspan="1">6 (2.5)</td><td colspan="1" rowspan="1">5 (4.1)</td><td colspan="1" rowspan="1">1 (0.8)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">1 (0.4)</td><td colspan="1" rowspan="1">0 (0.0)</td><td colspan="1" rowspan="1">1 (0.8)</td></tr><tr><td colspan="4" rowspan="1">WHO Performance Status, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;1</td><td colspan="1" rowspan="1">171 (71.0)</td><td colspan="1" rowspan="1">81 (67.5)</td><td colspan="1" rowspan="1">90 (74.4)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;2</td><td colspan="1" rowspan="1">70 (29.1)</td><td colspan="1" rowspan="1">39 (32.5)</td><td colspan="1" rowspan="1">31 (25.6)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">1 (0.4)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">0 (0.0)</td></tr><tr><td colspan="1" rowspan="1">ADL motor ability (AMPS), mean (SD)<sup><xref ref-type="table-fn" rid="table-fn3-0269216317747199">a</xref></sup></td><td colspan="1" rowspan="1">1.13 (0.59)</td><td colspan="1" rowspan="1">1.12 (0.58)</td><td colspan="1" rowspan="1">1.14 (0.59)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Below competence cut-off, <italic>n</italic> (%)<sup><xref ref-type="table-fn" rid="table-fn4-0269216317747199">b</xref></sup></td><td colspan="1" rowspan="1">230 (95.4)</td><td colspan="1" rowspan="1">117 (97.5)</td><td colspan="1" rowspan="1">113 (93.4)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">1 (0.4)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">0 (0.0)</td></tr><tr><td colspan="1" rowspan="1">ADL process ability (AMPS), mean (SD)<sup><xref ref-type="table-fn" rid="table-fn3-0269216317747199">a</xref></sup></td><td colspan="1" rowspan="1">0.84 (0.39)</td><td colspan="1" rowspan="1">0.85 (0.39)</td><td colspan="1" rowspan="1">0.84 (0.38)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Below competence cut-off, <italic>n</italic> (%)<sup><xref ref-type="table-fn" rid="table-fn4-0269216317747199">b</xref></sup></td><td colspan="1" rowspan="1">142 (58.9)</td><td colspan="1" rowspan="1">71 (59.2)</td><td colspan="1" rowspan="1">71 (58.7)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">1 (0.4)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">0 (0.0)</td></tr><tr><td colspan="1" rowspan="1">IPPA mean score (SD)<sup><xref ref-type="table-fn" rid="table-fn5-0269216317747199">c</xref>,<xref ref-type="table-fn" rid="table-fn6-0269216317747199">d</xref></sup></td><td colspan="1" rowspan="1">14.26 (4.06)</td><td colspan="1" rowspan="1">14.16 (3.65)</td><td colspan="1" rowspan="1">14.35 (4.45)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">3 (1.2)</td><td colspan="1" rowspan="1">0 (0.0)</td><td colspan="1" rowspan="1">3 (3.3)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Number of activity problems, <italic>n</italic> (%)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#x02003;&#x02003;0</td><td colspan="1" rowspan="1">64 (26.6)</td><td colspan="1" rowspan="1">33 (27.5)</td><td colspan="1" rowspan="1">31 (25.6)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;&#x02003;1&#x02013;3</td><td colspan="1" rowspan="1">76 (31.5)</td><td colspan="1" rowspan="1">35 (29.2)</td><td colspan="1" rowspan="1">41 (33.9)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;&#x02003;&#x0003e;3</td><td colspan="1" rowspan="1">101 (41.9)</td><td colspan="1" rowspan="1">52 (43.3)</td><td colspan="1" rowspan="1">49 (40.5)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">1 (0.4)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">0 (0.0)</td></tr><tr><td colspan="1" rowspan="1">HRQoL (QLQ-C30), mean (SD)<sup><xref ref-type="table-fn" rid="table-fn7-0269216317747199">e</xref>,<xref ref-type="table-fn" rid="table-fn8-0269216317747199">f</xref></sup></td><td colspan="1" rowspan="1">58.51 (21.98)</td><td colspan="1" rowspan="1">57.64 (22.7)</td><td colspan="1" rowspan="1">59.38 (21.4)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">2 (0.8)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">1 (0.8)</td></tr><tr><td colspan="1" rowspan="1">Autonomy indoor (IPA-DK), median (IQR)<sup><xref ref-type="table-fn" rid="table-fn9-0269216317747199">g</xref></sup></td><td colspan="1" rowspan="1">0 (0&#x02013;1)</td><td colspan="1" rowspan="1">0 (0&#x02013;1)</td><td colspan="1" rowspan="1">0 (0&#x02013;1)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">2 (0.8)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">1 (0.8)</td></tr><tr><td colspan="1" rowspan="1">Family role (IPA-DK), median (IQR)<sup><xref ref-type="table-fn" rid="table-fn9-0269216317747199">g</xref></sup></td><td colspan="1" rowspan="1">1 (0&#x02013;2)</td><td colspan="1" rowspan="1">1 (0&#x02013;2)</td><td colspan="1" rowspan="1">1 (0&#x02013;2)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">3 (1.2)</td><td colspan="1" rowspan="1">1 (0.8)</td><td colspan="1" rowspan="1">2 (1.7)</td></tr><tr><td colspan="1" rowspan="1">Social relations (IPA-DK), median (IQR)<sup><xref ref-type="table-fn" rid="table-fn9-0269216317747199">g</xref></sup></td><td colspan="1" rowspan="1">0 (0&#x02013;1)</td><td colspan="1" rowspan="1">0 (0&#x02013;1)</td><td colspan="1" rowspan="1">0 (0&#x02013;0)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Missing, <italic>n</italic> (%)</td><td colspan="1" rowspan="1">5 (2.1)</td><td colspan="1" rowspan="1">3 (2.5)</td><td colspan="1" rowspan="1">2 (1.7)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn2-0269216317747199"><p>SD: standard deviation; AUH: Aarhus University Hospital; OUH: Odense University Hospital; WHO: World Health Organization; ADL: activities of daily living; AMPS: Assessment of Motor and Process Skills; IPPA: Individually Prioritised Problem Assessment; HRQoL: health-related quality of life; QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of life C-30; IPA-DK: The Danish Version (IPA-DK) of the Impact on Participation and Autonomy Questionnaire (IPAQ); IQR: interquartile range.</p></fn><fn id="table-fn3-0269216317747199"><label>a</label><p>Higher positive measures represent a greater degree of ADL ability.</p></fn><fn id="table-fn4-0269216317747199"><label>b</label><p>Below competent cut-off on the ADL motor ability (&#x0003c;2.0 logits) and the ADL process ability (&#x0003c;1.0 logits).</p></fn><fn id="table-fn5-0269216317747199"><label>c</label><p>The IPPA score ranges from 1 to 25, with higher scores indicating a greater degree of difficulty performing prioritised everyday activities.</p></fn><fn id="table-fn6-0269216317747199"><label>d</label><p>Only includes participants with at least one prioritised activity problem (intervention group: <italic>n</italic>&#x02009;=&#x02009;87 and control group: <italic>n</italic>&#x02009;=&#x02009;90).</p></fn><fn id="table-fn7-0269216317747199"><label>e</label><p>The global health status/quality of life scale from the EORTC QLQ C-30 is used to assess HRQoL.</p></fn><fn id="table-fn8-0269216317747199"><label>f</label><p>The HRQoL ranges from 0 to 100, with higher scores indicating a greater degree of HRQoL.</p></fn><fn id="table-fn9-0269216317747199"><label>g</label><p>The IPA-DK ranges from 0 to 4, with 0 being no perceived participation restrictions and 4 being severe perceived participation restrictions.</p></fn></table-wrap-foot></table-wrap><p>We found the two groups comparable at baseline, but did see slightly more women in the control group. We therefore adjusted for gender in the sensitivity analyses.</p></sec><sec id="section25-0269216317747199"><title>Delivered interventions</title><p>Eight participants declined the intervention (6.61%). The remainder of the intervention group received the mandatory component 1 (113 (93.4%)). The median number of delivered components was three. A total of 36 participants (29.8%) received more than one home visit, and 62 participants (51.2%) received at least one follow-up telephone contact (<xref ref-type="table" rid="table3-0269216317747199">Table 3</xref>). Agreement between the D-OTs&#x02019; estimate of group allocation and the actual allocation was 66.2% (<italic>k</italic>&#x02009;=&#x02009;0.32 (95% CI: 0.21&#x02212;0.44)), indicating weak agreement. Five participants (4.1%) in the control group received some element of OT from their local municipality during T1&#x02013;T2 and two participants (1.7%) from T2&#x02013;T3.</p><table-wrap id="table3-0269216317747199" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Components from the &#x02018;Cancer Home-Life Intervention&#x02019; delivered to the participants in the intervention group (<italic>N</italic>&#x02009;=&#x02009;121)<sup><xref ref-type="table-fn" rid="table-fn11-0269216317747199">a</xref></sup> and total number of home visits, telephone follow-up contacts and time.</p></caption><alternatives><graphic xlink:href="10.1177_0269216317747199-table3"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">The &#x02018;Cancer Home-Life Intervention&#x02019;</th><th colspan="1" rowspan="1"/></tr></thead><tbody><tr><td colspan="2" rowspan="1">Components given by the intervention occupational therapist, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">1. Interview</td><td colspan="1" rowspan="1">113 (93.4)</td></tr><tr><td colspan="1" rowspan="1">2. Prioritise resources, energy and activities</td><td colspan="1" rowspan="1">73 (60.3)</td></tr><tr><td colspan="1" rowspan="1">3. Adaptation of activities</td><td colspan="1" rowspan="1">70 (57.9)</td></tr><tr><td colspan="1" rowspan="1">4. Adaptation of posture and seated positioning</td><td colspan="1" rowspan="1">37 (30.6)</td></tr><tr><td colspan="1" rowspan="1">5. Assistive technology</td><td colspan="1" rowspan="1">65 (53.7)</td></tr><tr><td colspan="1" rowspan="1">6. Modification of the physical home environment</td><td colspan="1" rowspan="1">11 (9.1)</td></tr><tr><td colspan="2" rowspan="1">Number of components per participant, median (IQR)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Number</td><td colspan="1" rowspan="1">3 (2&#x02013;4)</td></tr><tr><td colspan="2" rowspan="1">Home visits, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;First home visit</td><td colspan="1" rowspan="1">113 (93.4)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Second home visit</td><td colspan="1" rowspan="1">32 (26.4)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Third home visit</td><td colspan="1" rowspan="1">4 (3.3)</td></tr><tr><td colspan="2" rowspan="1">Time, median minutes (IQR)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;First home visit</td><td colspan="1" rowspan="1">105 (90&#x02013;120)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Second home visit</td><td colspan="1" rowspan="1">45 (30&#x02013;75)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Third home visit</td><td colspan="1" rowspan="1">45 (22.5&#x02013;75)</td></tr><tr><td colspan="2" rowspan="1">Telephone follow-up, <italic>n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;No follow-up telephone contact</td><td colspan="1" rowspan="1">13 (10.7)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;First follow-up telephone contact</td><td colspan="1" rowspan="1">62 (51.2)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Second follow-up telephone contact</td><td colspan="1" rowspan="1">39 (32.2)</td></tr><tr><td colspan="1" rowspan="1">&#x02003;Third follow-up telephone contact</td><td colspan="1" rowspan="1">7 (5.8)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn10-0269216317747199"><p>IQR: interquartile range.</p></fn><fn id="table-fn11-0269216317747199"><label>a</label><p>Eight participants did not want to receive the intervention.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section26-0269216317747199"><title>The primary outcome</title><p>ADL motor ability decreased in both groups during T1&#x02013;T3 (<xref ref-type="fig" rid="fig2-0269216317747199">Figure 2(a)</xref>). The within-group change was small (intervention group: &#x02212;0.14 logits (95% CI: &#x02212;0.27 to 0.00)) (control group: &#x02212;0.10 logits (95 CI: &#x02212;0.24 to 0.05); <xref ref-type="table" rid="table4-0269216317747199">Table 4</xref>) with the change in the intervention group being borderline significant. We observed no statistically significant effect of the &#x02018;Cancer Home-Life Intervention&#x02019; on the primary outcome from T1&#x02013;T3 (between-group mean change in ADL motor ability: &#x02212;0.04 logits (95% CI: &#x02212;0.23 to 0.15); <italic>p&#x02009;=&#x02009;</italic>0.69; <xref ref-type="table" rid="table4-0269216317747199">Table 4</xref>). Sensitivity analyses did not change the results.</p><fig id="fig2-0269216317747199" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Change over time and between-group differences. ADL=Activities of Daily Living; AMPS=Assessment of Motor and Process Skills; IPPA=Individually Prioritised Problem Assessment; HRQoL=Health-related Quality of Life; QLQ-C30=European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C-30.</p></caption><graphic xlink:href="10.1177_0269216317747199-fig2"/></fig><table-wrap id="table4-0269216317747199" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Mean change in primary outcome and secondary outcomes from baseline (T1) to six- (T2) and 12-week follow-up (T3) and odds ratio for no perceived participation restrictions; complete case analysis.</p></caption><alternatives><graphic xlink:href="10.1177_0269216317747199-table4"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Outcomes</th><th align="left" colspan="1" rowspan="1">
<italic>n</italic>
</th><th align="left" colspan="1" rowspan="1">Intervention group<hr/></th><th align="left" colspan="1" rowspan="1">
<italic>n</italic>
</th><th align="left" colspan="1" rowspan="1">Control group<hr/></th><th align="left" colspan="1" rowspan="2">Between-group mean change (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic>p</italic> value</th></tr><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Mean change</th><th colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Mean change</th><th colspan="1" rowspan="1"/></tr></thead><tbody><tr><td colspan="7" rowspan="1">
<italic>AMPS</italic>
</td></tr><tr><td colspan="1" rowspan="1">ADL motor ability T1&#x02013;T3<sup><xref ref-type="table-fn" rid="table-fn13-0269216317747199">a</xref>,<xref ref-type="table-fn" rid="table-fn14-0269216317747199">b</xref>,<xref ref-type="table-fn" rid="table-fn15-0269216317747199">c</xref>,<xref ref-type="table-fn" rid="table-fn16-0269216317747199">d</xref></sup></td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">&#x02212;0.14 (&#x02212;0.27 to 0.00)</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">&#x02212;0.10 (&#x02212;0.24 to 0.05)</td><td colspan="1" rowspan="1">&#x02212;0.04 (&#x02212;0.23 to 0.15)</td><td colspan="1" rowspan="1">0.69</td></tr><tr><td colspan="1" rowspan="1">ADL process ability T1&#x02013;T3<sup><xref ref-type="table-fn" rid="table-fn13-0269216317747199">a</xref>,<xref ref-type="table-fn" rid="table-fn14-0269216317747199">b</xref>,<xref ref-type="table-fn" rid="table-fn15-0269216317747199">c</xref>,<xref ref-type="table-fn" rid="table-fn16-0269216317747199">d</xref></sup></td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">&#x02212;0.10 (&#x02212;0.20 to &#x02212;0.01)</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">&#x02212;0.04 (&#x02212;0.14 to 0.06)</td><td colspan="1" rowspan="1">&#x02212;0.06 (&#x02212;0.20 to 0.07)</td><td colspan="1" rowspan="1">0.37</td></tr><tr><td colspan="7" rowspan="1">
<italic>IPPA</italic>
</td></tr><tr><td colspan="1" rowspan="1">IPPA score T1&#x02013;T2<sup><xref ref-type="table-fn" rid="table-fn15-0269216317747199">c</xref>,<xref ref-type="table-fn" rid="table-fn16-0269216317747199">d</xref>,<xref ref-type="table-fn" rid="table-fn17-0269216317747199">e</xref></sup></td><td colspan="1" rowspan="1">67</td><td colspan="1" rowspan="1">&#x02212;1.27 (&#x02212;2.01 to &#x02212;0.53)</td><td colspan="1" rowspan="1">65</td><td colspan="1" rowspan="1">&#x02212;1.16 (&#x02212;1.91 to &#x02212;0.41)</td><td colspan="1" rowspan="1">&#x02212;0.11 (&#x02212;1.17 to 0.95)</td><td colspan="1" rowspan="1">0.83</td></tr><tr><td colspan="1" rowspan="1">IPPA score T1&#x02013;T3<sup><xref ref-type="table-fn" rid="table-fn15-0269216317747199">c</xref>,<xref ref-type="table-fn" rid="table-fn16-0269216317747199">d</xref>,<xref ref-type="table-fn" rid="table-fn17-0269216317747199">e</xref></sup></td><td colspan="1" rowspan="1">62</td><td colspan="1" rowspan="1">&#x02212;1.38 (&#x02212;2.35 to &#x02212;0.40)</td><td colspan="1" rowspan="1">63</td><td colspan="1" rowspan="1">&#x02212;1.03 (&#x02212;2.00 to &#x02212;0.05)</td><td colspan="1" rowspan="1">&#x02212;0.35 (&#x02212;1.71 to 1.01)</td><td colspan="1" rowspan="1">0.61</td></tr><tr><td colspan="7" rowspan="1">
<italic>EORTC QLQ C-30</italic>
</td></tr><tr><td colspan="1" rowspan="1">HRQoL T1&#x02013;T2<sup><xref ref-type="table-fn" rid="table-fn15-0269216317747199">c</xref>,<xref ref-type="table-fn" rid="table-fn16-0269216317747199">d</xref>,<xref ref-type="table-fn" rid="table-fn18-0269216317747199">f</xref>,<xref ref-type="table-fn" rid="table-fn19-0269216317747199">g</xref></sup></td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">&#x02212;1.40 (&#x02212;5.49 to 2.68)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">&#x02212;1.19 (&#x02212;5.39 to 3.01)</td><td colspan="1" rowspan="1">&#x02212;0.21 (&#x02212;5.97 to 5.54)</td><td colspan="1" rowspan="1">0.94</td></tr><tr><td colspan="1" rowspan="1">HRQoL T1&#x02013;T3<sup><xref ref-type="table-fn" rid="table-fn15-0269216317747199">c</xref>,<xref ref-type="table-fn" rid="table-fn16-0269216317747199">d</xref>,<xref ref-type="table-fn" rid="table-fn18-0269216317747199">f</xref>,<xref ref-type="table-fn" rid="table-fn19-0269216317747199">g</xref></sup></td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">1.50 (&#x02212;2.97 to 5.97)</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">3.11 (&#x02212;1.52 to 7.74)</td><td colspan="1" rowspan="1">&#x02212;1.61 (&#x02212;7.95 to 4.73)</td><td colspan="1" rowspan="1">0.62</td></tr><tr><th align="left" colspan="1" rowspan="1">Outcomes</th><th align="left" colspan="1" rowspan="1">
<italic>n</italic>
</th><th align="left" colspan="1" rowspan="1">Intervention group<hr/></th><th align="left" colspan="1" rowspan="1">
<italic>n</italic>
</th><th align="left" colspan="1" rowspan="1">Control group<hr/></th><th align="left" colspan="1" rowspan="2">Odds ratio for no perceived participation restrictions (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic>p</italic> value</th></tr><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Odds<sup><xref ref-type="table-fn" rid="table-fn21-0269216317747199">i</xref></sup></th><th colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Odds<sup><xref ref-type="table-fn" rid="table-fn22-0269216317747199">j</xref></sup></th><th colspan="1" rowspan="1"/></tr><tr><td colspan="7" rowspan="1">
<italic>IPA-DK</italic>
<sup><xref ref-type="table-fn" rid="table-fn20-0269216317747199">h</xref></sup>
</td></tr><tr><td colspan="1" rowspan="1">Autonomy Indoor T2</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">7.64 (4.07 to 14.32)</td><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">6.00 (3.36 to 10.79)</td><td colspan="1" rowspan="1">1.27 (0.54 to 3.02)<sup><xref ref-type="table-fn" rid="table-fn22-0269216317747199">j</xref>,<xref ref-type="table-fn" rid="table-fn23-0269216317747199">k</xref></sup></td><td colspan="1" rowspan="1">0.59</td></tr><tr><td colspan="1" rowspan="1">Autonomy Indoor T3</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">8.89 (4.46 to 17.71)</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">8.67 (4.35 to 17.28)</td><td colspan="1" rowspan="1">1.03 (0.39 to 2.75)<sup><xref ref-type="table-fn" rid="table-fn22-0269216317747199">j</xref>,<xref ref-type="table-fn" rid="table-fn23-0269216317747199">k</xref></sup></td><td colspan="1" rowspan="1">0.95</td></tr><tr><td colspan="1" rowspan="1">Family role T2</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">1.21 (0.81 to 1.81)</td><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">1.39 (0.92 to 2.12)</td><td colspan="1" rowspan="1">0.83 (0.46 to 1.50)<sup><xref ref-type="table-fn" rid="table-fn22-0269216317747199">j</xref>,<xref ref-type="table-fn" rid="table-fn23-0269216317747199">k</xref></sup></td><td colspan="1" rowspan="1">0.54</td></tr><tr><td colspan="1" rowspan="1">Family role T3</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">1.70 (1.10 to 2.61)</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">1.56 (1.01 to 2.40)</td><td colspan="1" rowspan="1">1.08 (0.59 to 1.99)<sup><xref ref-type="table-fn" rid="table-fn22-0269216317747199">j</xref>,<xref ref-type="table-fn" rid="table-fn23-0269216317747199">k</xref></sup></td><td colspan="1" rowspan="1">0.81</td></tr><tr><td colspan="1" rowspan="1">Social relations T2</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">18.00 (7.31 to 44.30)</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">13.83 (6.04 to 31.68)</td><td colspan="1" rowspan="1">1.22 (0.35 to 4.21)<sup><xref ref-type="table-fn" rid="table-fn22-0269216317747199">j</xref>,<xref ref-type="table-fn" rid="table-fn23-0269216317747199">k</xref></sup></td><td colspan="1" rowspan="1">0.75</td></tr><tr><td colspan="1" rowspan="1">Social relations T3</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">11.71 (5.41 to 25.34)</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">13.50 (5.89 to 30.94)</td><td colspan="1" rowspan="1">0.86 (0.28 to 2.69)<sup><xref ref-type="table-fn" rid="table-fn22-0269216317747199">j</xref>,<xref ref-type="table-fn" rid="table-fn23-0269216317747199">k</xref></sup></td><td colspan="1" rowspan="1">0.80</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn12-0269216317747199"><p>AMPS: Assessment of Motor and Process Skills; ADL: activities of daily living; IPPA: Individually Prioritised Problem Assessment; IPA-DK: The Danish Version (IPA-DK) of the Impact on Participation and Autonomy Questionnaire (IPAQ); EORTC QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C-30; HRQoL: Health-related Quality of Life.</p></fn><fn id="table-fn13-0269216317747199"><label>a</label><p>Higher positive measures represent a greater degree of ADL ability.</p></fn><fn id="table-fn14-0269216317747199"><label>b</label><p>Exponential transformation of the difference between groups did not change the results.</p></fn><fn id="table-fn15-0269216317747199"><label>c</label><p>Multiple linear regression adjusted for hospital. The estimates are shown in the table.</p></fn><fn id="table-fn16-0269216317747199"><label>d</label><p>Multiple linear regression adding gender in the model did not change the results and are therefore not shown in table.</p></fn><fn id="table-fn17-0269216317747199"><label>e</label><p>The IPPA score ranges from 1 to 25, with higher scores indicating a greater degree of difficulty performing prioritised everyday activities.</p></fn><fn id="table-fn18-0269216317747199"><label>f</label><p>The global health status/quality of life scale from the EORTC QLQ C-30 is used to assess HRQoL.</p></fn><fn id="table-fn19-0269216317747199"><label>g</label><p>The HRQoL ranges from 0 to 100, with higher scores indicating a greater degree of HRQoL.</p></fn><fn id="table-fn20-0269216317747199"><label>h</label><p>The IPA-DK were dichotomised into &#x02018;no perceived participation restrictions&#x02019; and &#x02018;perceived participation restrictions&#x02019;.</p></fn><fn id="table-fn21-0269216317747199"><label>i</label><p>Odds for no perceived participation restrictions.</p></fn><fn id="table-fn22-0269216317747199"><label>j</label><p>Logistic regression adjusted for hospital. The estimates are shown in the table.</p></fn><fn id="table-fn23-0269216317747199"><label>k</label><p>Logistic regression adding gender in the model did not change the results and are therefore not shown in table.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section27-0269216317747199"><title>Secondary outcomes</title><p>Both groups&#x02019; ADL process ability decreased during T1&#x02013;T3 (<xref ref-type="fig" rid="fig2-0269216317747199">Figure 2(b)</xref>). The two groups experienced statistically less difficulty performing their prioritised everyday activities over time (<xref ref-type="table" rid="table4-0269216317747199">Table 4</xref>). Small within-group change was found concerning HRQoL, decreasing during T1&#x02013;T2 and increasing during the last follow-up (<xref ref-type="fig" rid="fig2-0269216317747199">Figure 2(d)</xref>). The probability of no perceived participation restrictions was high for both groups at both follow-ups. No statistically significant between-group differences were found (<xref ref-type="table" rid="table4-0269216317747199">Table 4</xref>). Sensitivity analyses confirmed the results of no intervention effect.</p></sec></sec><sec sec-type="discussion" id="section28-0269216317747199"><title>Discussion</title><p>This RCT evaluated the efficacy of the &#x02018;Cancer Home-Life Intervention&#x02019; compared with usual care alone in people with advanced cancer living at home. We found no statistically significant effect of the OT-based intervention (<xref ref-type="table" rid="table4-0269216317747199">Table 4</xref>).</p><p>Overall, our trial demonstrates high internal validity with limited and equal attrition between the groups, blinded assessors, sufficient statistical power and successfully performed randomisation. Below we discuss several aspects that need to be considered before one hastily concludes that OT-based interventions has no effect in people with advanced cancer.</p><sec id="section29-0269216317747199"><title>Intervention intensity</title><p>The delivered &#x02018;Cancer Home-Life Intervention&#x02019; was tailored and adjusted to the participants. In this study, this resulted in the intervention mainly encompassing three components, most of which were used during one home visit (median minutes&#x02009;=&#x02009;105) and one telephone contact over a 3-week time span (<xref ref-type="table" rid="table3-0269216317747199">Table 3</xref>). One explanation for why the &#x02018;Cancer Home-Life Intervention&#x02019; showed no effect in this study may be that the intensity of the intervention was too low. An important question in this respect is what is a minimum of OT-based intervention required to instil change. To our knowledge, no clear cut-off of the minimum intensity required to instil change exists.<sup><xref rid="bibr48-0269216317747199" ref-type="bibr">48</xref></sup> A systematic review<sup><xref rid="bibr49-0269216317747199" ref-type="bibr">49</xref></sup> found short-term effects on ADL and prioritised everyday activities of low intensity OT-based interventions in older people delivered over 2.5&#x02013;6&#x02009;months with a mean intensity varying from 0.8 to 3.4 intervention sessions per month.<sup><xref rid="bibr49-0269216317747199" ref-type="bibr">49</xref></sup> The literature on behavioural change would argue that one home visit and one telephone contact is not enough to change strategies and achieve change, as this requires more therapeutic support over longer periods of time.<sup><xref rid="bibr50-0269216317747199" ref-type="bibr">50</xref></sup> However, a telephone-delivered problem-solving OT-based intervention by Hegel et al.<sup><xref rid="bibr29-0269216317747199" ref-type="bibr">29</xref></sup> lasted on average 106&#x02009;min, and they found effect on function, HRQoL and emotional state. This amount of time almost equals the time used in our intervention. When we designed the trial, we decided that 1&#x02013;3 visit would be enough &#x02013; partly based on the trial by Hegel et al.<sup><xref rid="bibr29-0269216317747199" ref-type="bibr">29</xref></sup> Moreover, we had expected that most participants would receive more than one visit. However, based on our results and the knowledge of behaviour change theory,<sup><xref rid="bibr50-0269216317747199" ref-type="bibr">50</xref></sup> one may consider if we should have delivered the intervention over a longer period of time and increased the intensity.</p></sec><sec id="section30-0269216317747199"><title>Feasibility</title><p>We did not conduct a full feasibility study before the trial as advocated by the Medical Research Council,<sup><xref rid="bibr51-0269216317747199" ref-type="bibr">51</xref></sup> since our cross-sectional study gave us knowledge about relevant outcomes, and we had sufficient information for estimating sample size, recruitment and so on.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup> Furthermore, we had explored the acceptability and usefulness of the intervention in four people with advanced cancer, which showed that they definitely would value such an intervention.<sup><xref rid="bibr12-0269216317747199" ref-type="bibr">12</xref></sup> Still, a full feasibility study could have given us important information about required intervention intensity and intervention relevance.</p></sec><sec id="section31-0269216317747199"><title>Outcomes</title><p>Many people with advanced cancer face serious difficulties with ADL,<sup><xref rid="bibr5-0269216317747199" ref-type="bibr">5</xref>,<xref rid="bibr6-0269216317747199" ref-type="bibr">6</xref>,<xref rid="bibr8-0269216317747199" ref-type="bibr">8</xref>,<xref rid="bibr9-0269216317747199" ref-type="bibr">9</xref></sup> which motivated our choice of ADL as the primary trial outcome.<sup><xref rid="bibr8-0269216317747199" ref-type="bibr">8</xref></sup> However, they also experience difficulties in other areas at home, such as leisure and creative activities,<sup><xref rid="bibr7-0269216317747199" ref-type="bibr">7</xref></sup> which our intervention was also designed to solve.</p><p>Selecting outcome measures that capture the essence of an intervention is challenging, especially in people with advanced cancer with complex and diverse needs.<sup><xref rid="bibr6-0269216317747199" ref-type="bibr">6</xref></sup> Outcome measures in palliative care need to be psychometrically robust and sensitive to capture change over time.<sup><xref rid="bibr52-0269216317747199" ref-type="bibr">52</xref></sup> Sensitivity to change is particularly important when evaluating intervention effect. We selected the AMPS as an ADL measure because it is highly sensitive<sup><xref rid="bibr13-0269216317747199" ref-type="bibr">13</xref></sup> and more sensitive in oncology patients than other tools.<sup><xref rid="bibr53-0269216317747199" ref-type="bibr">53</xref></sup> However, the &#x02018;Cancer Home-Life Intervention&#x02019; targeted participants&#x02019; prioritised everyday activity problems which do not always include ADL. This could have affected the causal connection between the &#x02018;Cancer Home-Life Intervention&#x02019; and the AMPS, which may have been too narrow in scope.</p></sec><sec id="section32-0269216317747199"><title>Recruitment</title><p>Recruiting the most relevant study population is another challenge. We may have included individuals without the most urgent need for the intervention since 26.6% of the participants reported no activity problems (<xref ref-type="table" rid="table2-0269216317747199">Table 2</xref>). We cannot rule out that this may have biased the results towards the null value as these people probably received a smaller amount of interventions. Over two-thirds of the participants had a WHO PS1, meaning that we mostly recruited better functioning people with advanced cancer. People with WHO PS1 still have difficulties performing physically strenuous activities but may have less difficulties performing ADL. However, their ADL ability measured with the AMPS clearly indicated need of assistance to live in the community. Nevertheless, this issue raises the question whether we have identified the most appropriate participants for an OT-based intervention since so many had no prioritised activity problem. A solution could have been to use self-reported activity problems as an inclusion criterion.</p></sec><sec id="section33-0269216317747199"><title>What this study adds</title><p>This study is the first full-scale, adequately powered RCT investigating the efficacy of an OT-based intervention in people with advanced cancer.<sup><xref rid="bibr54-0269216317747199" ref-type="bibr">54</xref>,<xref rid="bibr55-0269216317747199" ref-type="bibr">55</xref></sup> Our study demonstrates that it is feasible to conduct a full-scale RCT in this vulnerable group of people and that the majority of them want and need OT-based interventions that support their everyday activities at home. This underlines that even though our RCT produced no evidence supporting the benefits of the present OT-based intervention, research and clinical practice in palliative care still need to focus on how to enable everyday activities in people with advanced cancer, helping them to live their lives as fully as possible.</p></sec></sec><sec sec-type="conclusions" id="section34-0269216317747199"><title>Conclusion</title><p>The &#x02018;Cancer Home-Life Intervention&#x02019;, delivered mostly through a single home visit and a single follow-up telephone contact, was not effective in maintaining or improving participants&#x02019; everyday activities and HRQoL. Future studies should pay even more attention to intervention development, minimal intervention &#x02018;dose&#x02019; believed to make a change and feasibility testing.</p></sec></body><back><ack><p>The authors thank the participants, the employees from the hospitals and the OTs. They also thank our advisory board: Professor Malcolm Cutchin, Professor Anders Bonde Jensen, Professor Jens S&#x000f8;ndergaard and Associate Professor Eva Ejlersen W&#x000e6;hrens.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Declaration of conflicting interests:</bold> The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The TrygFonden and the Danish Cancer Society (R53-A2783), the University of Southern Denmark, the Danish Association of Occupational Therapists (FF 2 14 &#x02013; 3), and the Region of Southern Denmark (15/23775) funded the study.</p></fn><fn fn-type="other"><p><bold>ORCID iD:</bold> Marc Sampedro Pilegaard <inline-graphic xlink:href="10.1177_0269216317747199-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-6362-410X">https://orcid.org/0000-0001-6362-410X</ext-link></p></fn></fn-group><app-group><app><title>Appendix</title><table-wrap id="table5-0269216317747199" orientation="portrait" position="anchor"><label>Appendix 1.</label><caption><p>Description of the World Health Organization performance status.</p></caption><alternatives><graphic xlink:href="10.1177_0269216317747199-table5"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Grade</th><th align="left" colspan="1" rowspan="1">Explanation of activity</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">Fully active, able to carry on all pre-disease performance without restriction</td></tr><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, for example, light housework, office work</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">Capable of only limited self-care, confined to bed or chair more than 50% of waking hours</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Dead</td></tr></tbody></table></alternatives></table-wrap></app></app-group><ref-list><title>References</title><ref id="bibr1-0269216317747199"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashim</surname><given-names>D</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>The global decrease in cancer mortality: trends and disparities</article-title>. <source>Ann Oncol</source>
<year>2016</year>; <volume>27</volume>(<issue>5</issue>): <fpage>926</fpage>&#x02013;<lpage>933</lpage>.<pub-id pub-id-type="pmid">26802157</pub-id></mixed-citation></ref><ref id="bibr2-0269216317747199"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coleman</surname><given-names>MP</given-names></name><name><surname>Quaresma</surname><given-names>M</given-names></name><name><surname>Berrino</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Cancer survival in five continents: a worldwide population-based study (CONCORD)</article-title>. <source>Lancet Oncol</source>
<year>2008</year>; <volume>9</volume>(<issue>8</issue>): <fpage>730</fpage>&#x02013;<lpage>756</lpage>.<pub-id pub-id-type="pmid">18639491</pub-id></mixed-citation></ref><ref id="bibr3-0269216317747199"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Higginson</surname><given-names>IJ</given-names></name><name><surname>Sen-Gupta</surname><given-names>GJA</given-names></name></person-group>
<article-title>Place of care in advanced cancer: a qualitative systematic literature review of patient preferences</article-title>. <source>J Palliat Med</source>
<year>2000</year>; <volume>3</volume>(<issue>3</issue>): <fpage>287</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">15859670</pub-id></mixed-citation></ref><ref id="bibr4-0269216317747199"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gomes</surname><given-names>B</given-names></name><name><surname>Calanzani</surname><given-names>N</given-names></name><name><surname>Gysels</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Heterogeneity and changes in preferences for dying at home: a systematic review</article-title>. <source>BMC Palliat Care</source>
<year>2013</year>; <volume>12</volume>: <fpage>7</fpage>.<pub-id pub-id-type="pmid">23414145</pub-id></mixed-citation></ref><ref id="bibr5-0269216317747199"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheville</surname><given-names>AL</given-names></name><name><surname>Troxel</surname><given-names>AB</given-names></name><name><surname>Basford</surname><given-names>JR</given-names></name><etal>et al</etal></person-group>
<article-title>Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer</article-title>. <source>J Clin Oncol</source>
<year>2008</year>; <volume>26</volume>(<issue>16</issue>): <fpage>2621</fpage>&#x02013;<lpage>2629</lpage>.<pub-id pub-id-type="pmid">18509174</pub-id></mixed-citation></ref><ref id="bibr6-0269216317747199"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnsen</surname><given-names>AT</given-names></name><name><surname>Petersen</surname><given-names>MA</given-names></name><name><surname>Pedersen</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Do advanced cancer patients in Denmark receive the help they need? A nationally representative survey of the need related to 12 frequent symptoms/problems</article-title>. <source>Psychooncology</source>
<year>2013</year>; <volume>22</volume>(<issue>8</issue>): <fpage>1724</fpage>&#x02013;<lpage>1730</lpage>.<pub-id pub-id-type="pmid">23042603</pub-id></mixed-citation></ref><ref id="bibr7-0269216317747199"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peoples</surname><given-names>H</given-names></name><name><surname>Brandt</surname><given-names>&#x000c5;</given-names></name><name><surname>Waehrens</surname><given-names>EE</given-names></name><etal>et al</etal></person-group>
<article-title>Managing occupations in everyday life for people with advanced cancer living at home</article-title>. <source>Scand J Occup Ther</source>
<year>2016</year>; <volume>24</volume>(<issue>1</issue>): <fpage>57</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">27578556</pub-id></mixed-citation></ref><ref id="bibr8-0269216317747199"><label>8</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>W&#x000e6;hrens</surname><given-names>EE</given-names></name><name><surname>la Cour</surname><given-names>K</given-names></name><name><surname>Brandt</surname><given-names>&#x000c5;</given-names></name></person-group>
<article-title>The quality of ADL task performance based on self-report and observation in people living at home with cancer</article-title>. In: <conf-name>16th international congress of the world federation of occupational therapists</conf-name>, <conf-loc>Yokohama, Japan</conf-loc>, <conf-date>18&#x02013;21 June 2014</conf-date>.</mixed-citation></ref><ref id="bibr9-0269216317747199"><label>9</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Brandt</surname><given-names>&#x000c5;</given-names></name><name><surname>la Cour</surname><given-names>K</given-names></name><name><surname>W&#x000e6;hrens</surname><given-names>EE</given-names></name></person-group>
<article-title>Activity problems important to people with advanced cancer living at home</article-title>. In: <conf-name>16th international congress of the world federation of occupational therapists</conf-name>, <conf-loc>Yokohama, Japan</conf-loc>, <conf-date>18&#x02013;21 June 2014</conf-date>.</mixed-citation></ref><ref id="bibr10-0269216317747199"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rainbird</surname><given-names>K</given-names></name><name><surname>Perkins</surname><given-names>J</given-names></name><name><surname>Sanson-Fisher</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>The needs of patients with advanced, incurable cancer</article-title>. <source>Br J Cancer</source>
<year>2009</year>; <volume>101</volume>(<issue>5</issue>): <fpage>759</fpage>&#x02013;<lpage>764</lpage>.<pub-id pub-id-type="pmid">19654579</pub-id></mixed-citation></ref><ref id="bibr11-0269216317747199"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esbensen</surname><given-names>BA</given-names></name><name><surname>Osterlind</surname><given-names>K</given-names></name><name><surname>Hallberg</surname><given-names>IR</given-names></name></person-group>
<article-title>Quality of life of elderly persons with cancer: a 6-month follow-up</article-title>. <source>Scand J Caring Sci</source>
<year>2007</year>; <volume>21</volume>(<issue>2</issue>): <fpage>178</fpage>&#x02013;<lpage>190</lpage>.<pub-id pub-id-type="pmid">17559436</pub-id></mixed-citation></ref><ref id="bibr12-0269216317747199"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brandt</surname><given-names>A</given-names></name><name><surname>Pilegaard</surname><given-names>MS</given-names></name><name><surname>Oestergaard</surname><given-names>LG</given-names></name><etal>et al</etal></person-group>
<article-title>Effectiveness of the &#x02018;Cancer Home-Life Intervention&#x02019; on everyday activities and quality of life in people with advanced cancer living at home: a randomised controlled trial and an economic evaluation</article-title>. <source>BMC Palliat Care</source>
<year>2016</year>; <volume>15</volume>: <fpage>10</fpage>.<pub-id pub-id-type="pmid">26801394</pub-id></mixed-citation></ref><ref id="bibr13-0269216317747199"><label>13</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Fisher</surname><given-names>AG</given-names></name><name><surname>Jones</surname><given-names>KB</given-names></name></person-group>
<source>Assessment of motor and process skills: development, standardization, and administration manual</source>, <volume>vol. 2</volume>
<edition>8th ed.</edition>
<publisher-loc>Fort Collins, CO</publisher-loc>: <publisher-name>Three Star Press</publisher-name>, <year>2010</year>.</mixed-citation></ref><ref id="bibr14-0269216317747199"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reeve</surname><given-names>J</given-names></name><name><surname>Lloyd-Williams</surname><given-names>M</given-names></name><name><surname>Payne</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Revisiting biographical disruption: exploring individual embodied illness experience in people with terminal cancer</article-title>. <source>Health</source>: <year>2010</year>; <volume>14</volume>(<issue>2</issue>): <fpage>178</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">20164165</pub-id></mixed-citation></ref><ref id="bibr15-0269216317747199"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carter</surname><given-names>H</given-names></name><name><surname>Macleod</surname><given-names>R</given-names></name><name><surname>Brander</surname><given-names>P</given-names></name><etal>et al</etal></person-group>
<article-title>Living with a terminal illness: patients&#x02019; priorities</article-title>. <source>J Adv Nurs</source>
<year>2004</year>; <volume>45</volume>(<issue>6</issue>): <fpage>611</fpage>&#x02013;<lpage>620</lpage>.<pub-id pub-id-type="pmid">15012639</pub-id></mixed-citation></ref><ref id="bibr16-0269216317747199"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>La Cour</surname><given-names>K</given-names></name><name><surname>Johannessen</surname><given-names>H</given-names></name><name><surname>Scient</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Activity and meaning making in the everyday lives of people with advanced cancer</article-title>. <source>Palliat Support Care</source>
<year>2009</year>; <volume>7</volume>: <fpage>469</fpage>&#x02013;<lpage>479</lpage>.<pub-id pub-id-type="pmid">19939309</pub-id></mixed-citation></ref><ref id="bibr17-0269216317747199"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnston</surname><given-names>B</given-names></name></person-group>
<article-title>Can self-care become an integrated part of end of life care? Implications for palliative nursing</article-title>. <source>Int J Palliat Nurs</source>
<year>2010</year>; <volume>16</volume>(<issue>5</issue>): <fpage>212</fpage>&#x02013;<lpage>214</lpage>.<pub-id pub-id-type="pmid">20679968</pub-id></mixed-citation></ref><ref id="bibr18-0269216317747199"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cotterell</surname><given-names>P</given-names></name></person-group>
<article-title>Striving for independence: experiences and needs of service users with life-limiting conditions</article-title>. <source>J Adv Nurs</source>
<year>2008</year>; <volume>62</volume>(<issue>6</issue>): <fpage>665</fpage>&#x02013;<lpage>673</lpage>.<pub-id pub-id-type="pmid">18503650</pub-id></mixed-citation></ref><ref id="bibr19-0269216317747199"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>C</given-names></name><name><surname>Swami</surname><given-names>N</given-names></name><name><surname>Krzyzanowska</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial</article-title>. <source>Lancet Oncol</source>
<year>2014</year>; <volume>383</volume>: <fpage>1721</fpage>&#x02013;<lpage>1730</lpage>.</mixed-citation></ref><ref id="bibr20-0269216317747199"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Fitzgerald</surname><given-names>G</given-names></name><name><surname>Leurent</surname><given-names>B</given-names></name><etal>et al</etal></person-group>
<article-title>Rehabilitation in advanced, progressive, recurrent cancer: a randomized controlled trial</article-title>. <source>J Pain Symptom Manage</source>
<year>2013</year>; <volume>46</volume>(<issue>3</issue>): <fpage>315</fpage>&#x02013;<lpage>325</lpage>.<pub-id pub-id-type="pmid">23182307</pub-id></mixed-citation></ref><ref id="bibr21-0269216317747199"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gomes</surname><given-names>B</given-names></name><name><surname>Calanzani</surname><given-names>N</given-names></name><name><surname>Curiale</surname><given-names>V</given-names></name><etal>et al</etal></person-group>
<article-title>Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers</article-title>. <source>Cochrane Database Syst Rev</source>
<year>2013</year>; <volume>6</volume>: <fpage>CD007760</fpage>.</mixed-citation></ref><ref id="bibr22-0269216317747199"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oldervoll</surname><given-names>LM</given-names></name><name><surname>Loge</surname><given-names>JH</given-names></name><name><surname>Lydersen</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Physical exercise for cancer patients with advanced disease: a randomised controlled trial</article-title>. <source>Oncologist</source>
<year>2011</year>; <volume>16</volume>: <fpage>1649</fpage>&#x02013;<lpage>1657</lpage>.<pub-id pub-id-type="pmid">21948693</pub-id></mixed-citation></ref><ref id="bibr23-0269216317747199"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henke</surname><given-names>CC</given-names></name><name><surname>Cabri</surname><given-names>J</given-names></name><name><surname>Fricke</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Strength and endurance training in the treatment of lung cancer patients in stages IIIA/IIIB/IV</article-title>. <source>Support Care Cancer</source>
<year>2014</year>; <volume>22</volume>(<issue>1</issue>): <fpage>95</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="pmid">23995813</pub-id></mixed-citation></ref><ref id="bibr24-0269216317747199"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jensen</surname><given-names>W</given-names></name><name><surname>Baumann</surname><given-names>FT</given-names></name><name><surname>Stein</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Exercise training in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy: a pilot study</article-title>. <source>Support Care Cancer</source>
<year>2014</year>; <volume>22</volume>(<issue>7</issue>): <fpage>1797</fpage>&#x02013;<lpage>1806</lpage>.<pub-id pub-id-type="pmid">24531742</pub-id></mixed-citation></ref><ref id="bibr25-0269216317747199"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mayo</surname><given-names>NE</given-names></name><name><surname>Moriello</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>SC</given-names></name><etal>et al</etal></person-group>
<article-title>Pedometer-facilitated walking intervention shows promising effectiveness for reducing cancer fatigue: a pilot randomised trial</article-title>. <source>Clin Rehabil</source>
<year>2014</year>; <volume>28</volume>(<issue>12</issue>): <fpage>1198</fpage>&#x02013;<lpage>1209</lpage>.<pub-id pub-id-type="pmid">24917586</pub-id></mixed-citation></ref><ref id="bibr26-0269216317747199"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van den Dungen</surname><given-names>IA</given-names></name><name><surname>Verhagen</surname><given-names>CA</given-names></name><name><surname>van der Graaf</surname><given-names>WT</given-names></name><etal>et al</etal></person-group>
<article-title>Feasibility and impact of a physical exercise program in patients with advanced cancer: a pilot study</article-title>. <source>J Palliat Med</source>
<year>2014</year>; <volume>17</volume>(<issue>10</issue>): <fpage>1091</fpage>&#x02013;<lpage>1098</lpage>.<pub-id pub-id-type="pmid">25003635</pub-id></mixed-citation></ref><ref id="bibr27-0269216317747199"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burkhardt</surname><given-names>A</given-names></name><name><surname>Ivy</surname><given-names>M</given-names></name><name><surname>Kannenberg</surname><given-names>KR</given-names></name><etal>et al</etal></person-group>
<article-title>The role of occupational therapy in end-of-life care</article-title>. <source>Am J Occup Ther</source>
<year>2011</year>; <volume>65</volume>: <fpage>66</fpage>&#x02013;<lpage>75</lpage>.</mixed-citation></ref><ref id="bibr28-0269216317747199"><label>28</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Twycross</surname><given-names>R</given-names></name></person-group>
<source>Introducing palliative care</source>. <edition>4th ed.</edition>
<publisher-loc>Abingdon</publisher-loc>: <publisher-name>Radcliffe Medical Press</publisher-name>, <year>2003</year>.</mixed-citation></ref><ref id="bibr29-0269216317747199"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hegel</surname><given-names>MT</given-names></name><name><surname>Lyons</surname><given-names>KD</given-names></name><name><surname>Hull</surname><given-names>JG</given-names></name><etal>et al</etal></person-group>
<article-title>Feasibility study of a randomized controlled trial of a telephone-delivered problem-solving-occupational therapy intervention to reduce participation restrictions in rural breast cancer survivors undergoing chemotherapy</article-title>. <source>Psychooncology</source>
<year>2011</year>; <volume>20</volume>(<issue>10</issue>): <fpage>1092</fpage>&#x02013;<lpage>1101</lpage>.<pub-id pub-id-type="pmid">20821373</pub-id></mixed-citation></ref><ref id="bibr30-0269216317747199"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harrison-Paul</surname><given-names>J</given-names></name><name><surname>Drummond</surname><given-names>A</given-names></name></person-group>
<article-title>A randomised controlled trial of occupational therapy in oncology: challenges in conducting a pilot study</article-title>. <source>Br J Occup Ther</source>
<year>2006</year>; <volume>69</volume>(<issue>3</issue>): <fpage>130</fpage>&#x02013;<lpage>133</lpage>.</mixed-citation></ref><ref id="bibr31-0269216317747199"><label>31</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Lindahl-Jacobsen</surname><given-names>L</given-names></name></person-group>
<source>Occupational therapy for cancer patients &#x02013; a randomised, controlled study</source>. Phd Thesis, <publisher-name>University of Southern Denmark</publisher-name>, <publisher-loc>Odense</publisher-loc>, <year>2014</year>.</mixed-citation></ref><ref id="bibr32-0269216317747199"><label>32</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>S&#x000f6;derback</surname><given-names>I</given-names></name></person-group>
<source>International handbook of occupational therapy interventions</source>. <edition>2nd ed.</edition>
<publisher-loc>Cham</publisher-loc>: <publisher-name>Springer</publisher-name>, <year>2015</year>.</mixed-citation></ref><ref id="bibr33-0269216317747199"><label>33</label><mixed-citation publication-type="book">
<collab>World Health Organization</collab>. <article-title>World Health Organization (WHO) handbook for reporting results of cancer treatment</article-title>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>, <year>1979</year>, p. <fpage>45</fpage>.</mixed-citation></ref><ref id="bibr34-0269216317747199"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerber</surname><given-names>LH</given-names></name><name><surname>Hoffman</surname><given-names>K</given-names></name><name><surname>Chaudhry</surname><given-names>U</given-names></name><etal>et al</etal></person-group>
<article-title>Functional outcomes and life satisfaction in long-term survivors of pediatric sarcomas</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2006</year>; <volume>87</volume>(<issue>12</issue>): <fpage>1611</fpage>&#x02013;<lpage>1617</lpage>.<pub-id pub-id-type="pmid">17141641</pub-id></mixed-citation></ref><ref id="bibr35-0269216317747199"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parks</surname><given-names>R</given-names></name><name><surname>Rasch</surname><given-names>EK</given-names></name><name><surname>Mansky</surname><given-names>PJ</given-names></name></person-group>
<article-title>Differences in activities of daily living performance between long-term pediatric sarcoma survivors and a matched comparison group on standardized testing</article-title>. <source>Pediatr Blood Cancer</source>
<year>2009</year>; <volume>53</volume>(<issue>4</issue>): <fpage>622</fpage>&#x02013;<lpage>628</lpage>.<pub-id pub-id-type="pmid">19533662</pub-id></mixed-citation></ref><ref id="bibr36-0269216317747199"><label>36</label><mixed-citation publication-type="book">
<collab>Socialstyrelsen</collab>. <source>Dansk IPPA: Et Redskab Til at Afd&#x000e6;kke Aktivitetsproblemer I Hverdagen Og Evaluere Indsatser &#x02013; manual</source>. Report, <publisher-name>Socialstyrelsen</publisher-name>, <publisher-loc>Stockholm</publisher-loc>, <year>2013</year>.</mixed-citation></ref><ref id="bibr37-0269216317747199"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wessels</surname><given-names>R</given-names></name><name><surname>De Witte</surname><given-names>L</given-names></name><name><surname>Andrich</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>IPPA, a user-centred approach to assess effectiveness of assistive technology provision</article-title>. <source>Technol Disabil</source>
<year>2000</year>; <volume>13</volume>(<issue>1</issue>): <fpage>105</fpage>&#x02013;<lpage>115</lpage>.</mixed-citation></ref><ref id="bibr38-0269216317747199"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wessels</surname><given-names>R</given-names></name><name><surname>Persson</surname><given-names>J</given-names></name><name><surname>Lorentsen</surname><given-names>&#x000d8;</given-names></name><etal>et al</etal></person-group>
<article-title>IPPA: individually prioritised problem assessment</article-title>. <source>Technol Disabil</source>
<year>2002</year>; <volume>14</volume>(<issue>3</issue>): <fpage>141</fpage>&#x02013;<lpage>145</lpage>.</mixed-citation></ref><ref id="bibr39-0269216317747199"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghaziani</surname><given-names>E</given-names></name></person-group>
<article-title>Manual til den danske version af impact on participation and autonomy questionnaire (IPA-DK)</article-title>. <source>Report, Bispebjerg Hospital, Copenhagen</source>, <year>2013</year>.</mixed-citation></ref><ref id="bibr40-0269216317747199"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kersten</surname><given-names>P</given-names></name><name><surname>Cardol</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Validity of the impact on participation and autonomy questionnaire: a comparison between two countries</article-title>. <source>Disabil Rehabil</source>
<year>2007</year>; <volume>29</volume>(<issue>19</issue>): <fpage>1502</fpage>&#x02013;<lpage>1509</lpage>.<pub-id pub-id-type="pmid">17852246</pub-id></mixed-citation></ref><ref id="bibr41-0269216317747199"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cardol</surname><given-names>M</given-names></name><name><surname>de Haan</surname><given-names>RJ</given-names></name><name><surname>de Jong</surname><given-names>BA</given-names></name><etal>et al</etal></person-group>
<article-title>Psychometric properties of the impact on participation and autonomy questionnaire</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2001</year>; <volume>82</volume>(<issue>2</issue>): <fpage>210</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">11239312</pub-id></mixed-citation></ref><ref id="bibr42-0269216317747199"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cardol</surname><given-names>MBA</given-names></name><name><surname>van den Bos</surname><given-names>GA</given-names></name><name><surname>de Jong</surname><given-names>BA</given-names></name></person-group>
<article-title>Responsiveness of the impact on participation and autonomy questionnaire</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2002</year>; <volume>83</volume>: <fpage>1524</fpage>&#x02013;<lpage>1529</lpage>.<pub-id pub-id-type="pmid">12422319</pub-id></mixed-citation></ref><ref id="bibr43-0269216317747199"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghaziani</surname><given-names>E</given-names></name><name><surname>Krogh</surname><given-names>AG</given-names></name><name><surname>Lund</surname><given-names>H</given-names></name></person-group>
<article-title>Developing a Danish version of the &#x02018;impact on participation and autonomy questionnaire&#x02019;</article-title>. <source>Scand J Occup Ther</source>
<year>2013</year>; <volume>20</volume>(<issue>3</issue>): <fpage>190</fpage>&#x02013;<lpage>200</lpage>.<pub-id pub-id-type="pmid">23116294</pub-id></mixed-citation></ref><ref id="bibr44-0269216317747199"><label>44</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Fayers</surname><given-names>PM</given-names></name><name><surname>Aaronson</surname><given-names>NK</given-names></name><name><surname>Bjordal</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<source>The EORTC QLQ-C30 scoring manual</source>. <edition>3rd ed.</edition>
<publisher-loc>Brussels</publisher-loc>: <publisher-name>European Organisation for Research and Treatment of Cancer</publisher-name>, <year>2001</year>.</mixed-citation></ref><ref id="bibr45-0269216317747199"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Groenvold</surname><given-names>M</given-names></name><name><surname>Klee</surname><given-names>MC</given-names></name><name><surname>Sprangers</surname><given-names>MA</given-names></name></person-group>
<article-title>Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement</article-title>. <source>J Clin Epidemiol</source>
<year>1997</year>; <volume>50</volume>(<issue>4</issue>): <fpage>441</fpage>&#x02013;<lpage>450</lpage>.<pub-id pub-id-type="pmid">9179103</pub-id></mixed-citation></ref><ref id="bibr46-0269216317747199"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaasa</surname><given-names>S</given-names></name><name><surname>Bjordal</surname><given-names>K</given-names></name><name><surname>Aaronson</surname><given-names>N</given-names></name><etal>et al</etal></person-group>
<article-title>The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy</article-title>. <source>Eur J Cancer</source>
<year>1995</year>; <volume>31</volume>(<issue>13&#x02013;14</issue>): <fpage>2260</fpage>&#x02013;<lpage>2263</lpage>.</mixed-citation></ref><ref id="bibr47-0269216317747199"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickers</surname><given-names>AJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group>
<article-title>Analysing controlled trials with baseline and follow up measurements</article-title>. <source>BMJ</source>
<year>2001</year>; <volume>323</volume>: <fpage>1123</fpage>&#x02013;<lpage>1124</lpage>.<pub-id pub-id-type="pmid">11701584</pub-id></mixed-citation></ref><ref id="bibr48-0269216317747199"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fritz</surname><given-names>H</given-names></name><name><surname>Cutchin</surname><given-names>MP</given-names></name></person-group>
<article-title>Integrating the science of habit: opportunities for occupational therapy</article-title>. <source>OTJR</source>
<year>2016</year>; <volume>36</volume>(<issue>2</issue>): <fpage>92</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">27504882</pub-id></mixed-citation></ref><ref id="bibr49-0269216317747199"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>TL</given-names></name><name><surname>Petersen</surname><given-names>KS</given-names></name><name><surname>Nielsen</surname><given-names>CV</given-names></name><etal>et al</etal></person-group>
<article-title>What are the short-term and long-term effects of occupation-focused and occupation-based occupational therapy in the home on older adults&#x02019; occupational performance? A systematic review</article-title>. <source>Scand J Occup Ther</source>
<year>2017</year>; <volume>24</volume>: <fpage>235</fpage>&#x02013;<lpage>248</lpage>.<pub-id pub-id-type="pmid">27769123</pub-id></mixed-citation></ref><ref id="bibr50-0269216317747199"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwasnicka</surname><given-names>D</given-names></name><name><surname>Dombrowski</surname><given-names>SU</given-names></name><name><surname>White</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Theoretical explanations for maintenance of behaviour change: a systematic review of behaviour theories</article-title>. <source>Health Psychol Rev</source>
<year>2016</year>; <volume>10</volume>(<issue>3</issue>): <fpage>277</fpage>&#x02013;<lpage>296</lpage>.<pub-id pub-id-type="pmid">26854092</pub-id></mixed-citation></ref><ref id="bibr51-0269216317747199"><label>51</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Craig</surname><given-names>P</given-names></name><name><surname>Dieppe</surname><given-names>P</given-names></name><name><surname>Macintyre</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<source>Developing and evaluating complex interventions: new guidance</source>. Report, <publisher-name>Medical Research Council</publisher-name>, <publisher-loc>Swindon</publisher-loc>, <year>2008</year>.</mixed-citation></ref><ref id="bibr52-0269216317747199"><label>52</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Evans</surname><given-names>JC</given-names></name><name><surname>Benalia</surname><given-names>H</given-names></name><name><surname>Preston</surname><given-names>NJ</given-names></name><etal>et al</etal></person-group>
<article-title>The selection and use of outcome measures in palliative and end-of-life care research: the MORECare international consensus workshop</article-title>. <conf-name>J Pain Symptom Manage</conf-name>
<year>2013</year>; <volume>46</volume>(<issue>6</issue>): <fpage>925</fpage>&#x02013;<lpage>937</lpage>.</mixed-citation></ref><ref id="bibr53-0269216317747199"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choo</surname><given-names>SX</given-names></name><name><surname>Stratford</surname><given-names>P</given-names></name><name><surname>Richardson</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>Comparison of the sensitivity to change of the functional independence measure with the assessment of motor and process skills within different rehabilitation populations</article-title>. <source>Disabil Rehabil</source>. Epub ahead of print <day>10</day>
<month>9</month>
<year>2017</year>. DOI: 101080/09638288.2017.1375033.</mixed-citation></ref><ref id="bibr54-0269216317747199"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hunter</surname><given-names>EG</given-names></name><name><surname>Gibson</surname><given-names>RW</given-names></name><name><surname>Arbesman</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Systematic review of occupational therapy and adult cancer rehabilitation: part 1. Impact of physical activity and symptom management interventions</article-title>. <source>Am J Occup Ther</source>
<year>2017</year>; <volume>71</volume>(<issue>2</issue>): <fpage>7102100030</fpage>.</mixed-citation></ref><ref id="bibr55-0269216317747199"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hunter</surname><given-names>EG</given-names></name><name><surname>Gibson</surname><given-names>RW</given-names></name><name><surname>Arbesman</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Systematic review of occupational therapy and adult cancer rehabilitation: part 2. Impact of multidisciplinary rehabilitation and psychosocial, sexuality, and return-to-work interventions</article-title>. <source>Am J Occup Ther</source>
<year>2017</year>; <volume>71</volume>(<issue>2</issue>): <fpage>7102100040</fpage>.</mixed-citation></ref></ref-list></back></article>